Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Saturday, September 3, 2011

They Knew and Failed To . . .

"The fact that corporate executives so frequently make such callous decisions, and have always done so, shows the need for America's civil justice system. At a time when many advocate closing the courthouse doors, these stories give an indication of the dangers we would be exposed to without its protections. When government regulation can offer little more than a slap on the wrist and a small fine, the civil justice system is necessary to both detect such outrageous behavior and deter it in the future."

No comments:

Post a Comment